JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, announced the preliminary results of a research collabora ...

A term plan with return of premium has become a popular choice for people who want life cover and also prefer not to lose the money they spend on premiums.

Neuroblastoma Australia welcomed the news today: "On behalf of all families of children impacted by neuroblastoma, we welcome the TGA's decision to approve IFINWIL®. We urgently need treatments for ...

Bioengineered skin that mimics real human tissue offers a cruelty-free, accurate alternative to animal-based toxicity testing. 3D printing technology is used to create lifelike skin with living human ...

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the 2025 Greater Bay Area ...

The microsurgical reconstruction team at Chang Gung Memorial Hospital, Linkou has achieved a groundbreaking milestone with the world's first "Breast Sensory Autologous Nerve Recon ...

A recent analysis by Oxford Economics Africa commissioned by Malaria No More found that total U.S. malaria funding provided through the bilateral President's Malaria Initiative and the U.S.

Over 25 years ago, the Centers for Disease Control and Prevention (CDC) began systematically tracking autism prevalence in the United States. In 1970, the rate was 1 in 10,000. Today, the newly ...

Summit Professional Education has partnered with The Knowledge Tree, a leading provider of continuing education for mental health professionals, to expand its offerings beyond rehabilitation therapy ...

Being: Landmark Federal Plan Could Boost Average Life Expectancy by 2.6 Years for All Americans Read the full study published in PLOS One MORRISTOWN, N.J., April 16, 2025 /PRNewswire/ -- A ...

Our roadmap for the next two to four years includes strategic entry into emerging markets where Biosidus has established partnerships, with a long-term goal of reaching Europe and the United States.

Mid-afternoon dosing of inhaled corticosteroids may be the most effective timing for controlling asthma symptoms and ...